Expression of biomarkers vimentin and Metastasis Associated 1(MTA1) protein in different stages of laryngeal cancer and their impacts on survival

Jaimanti  Bakshi; Ganesh  Aggarwal; Naresh K  Panda; Rijuneeta  Gupta; Roshan K  Verma; Sushmita  Ghoshal; Amanjit  Bal; Amit  Bahl

doi:10.30574/gscarr.2021.9.3.0245

Authors

Jaimanti Bakshi Department of Otolaryngology & Head neck surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Ganesh Aggarwal Department of Otolaryngology & Head neck surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Naresh K Panda Department of Otolaryngology & Head neck surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Rijuneeta Gupta Department of Otolaryngology & Head neck surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Roshan K Verma Department of Otolaryngology & Head neck surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Sushmita Ghoshal Department of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Amanjit Bal Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Amit Bahl Department of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.

DOI:

https://doi.org/10.30574/gscarr.2021.9.3.0245

Keywords:

Laryngeal cancer, Biomarker, MTA1, Vimentin

Abstract

Laryngeal cancer is the second most common cancer after the lip and oral cavity cancer ofhead and neck region1. Laryngeal malignancy is the seventh most common malignancy in males in India. Total number of new laryngeal cancer and death from laryngeal cancer have been estimated 12410 and 3760 respectively in 20192. As per last survey available the number of new cases diagnosed and total number of deaths from laryngeal malignancy were 25,460 and 17,560 respectively in 2012 in India3 . The incidence of cancer larynx is 1.26-8.18 per 100,000 populations in different regions of India. Carcinoma larynx constitutes40% of all Head and Neck cancers. Squamous cell carcinoma constitutes 95% of all malignancies of larynx. Glottis being the most common subsite followed by supraglottis and the least common site is the subglottis. There is an increasing incidence rate of this malignancy among middle aged and elderly men and women throughout the world. Expression of Biomarkers at different stages of laryngeal cancers and their impact on survival can play a crucial role in future management of laryngeal malignancies. In spite of having different modalities of treatments like surgery, radiotherapy, chemoradiation, the prognosis of laryngeal malignancies is still poor. The most common adverse factor for laryngeal cancer has been found lymph node metastasis. The process of progression of LSCC is complex and difficult to know it completely. Despite multi-modality therapeutic advances in recent decades, improvements in overall survival and disease free survival is very less. In this study we emphasized the role of expression of biomarkers vimentin and metastasis associated 1(MTA1) protein in different stages of laryngeal cancer and their impacts on survival.

Metrics

Metrics Loading ...

References

Nima Daneshi, Mohammad Fararouei, Mohammad Mohammadianpanah, Mohammad Zare-Bandamiri, Somayeh Parvin, and Mostafa Dianatinasab, “Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study,” J Cancer Epidemiol, vol. 2018, Article ID 9678097, 8 pages

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Can J Clin. 2019Jan; 69(1):7-34.

Bobdey S, Jain A, Balasubramanium G. Epidemiological review of laryngeal cancer: An Indian perspective. Indian journal of medical and paediatric oncology: official Journal of Indian Society of Medical &Paediatric Oncology. 2015 Jul, 36(3), 154-160.

Greco A, De Virgilio A, Rizzo MI, Pandolfi F, Rosati D, de Vincentiis M. The prognostic role of E‐cadherin and β‐catenin overexpression in laryngeal squamous cell carcinoma, Laryngoscope. 2016 Apr;126(4):E148-55

Zhang H, Yang D, Wang H, Wen S, Liu J, Luan Q, Huang Y, Wang B, Lin C, Qian H. Metastasis-associated gene 1 promotes invasion and migration potential of laryngeal squamous cell carcinoma cells. Oncol Lett. 2014 Feb 1;7(2):399-404.

Zhu W, Li G, Guo H, Chen H, Xu X, Long J, Zeng C, Wang X. Clinicopathological Significance of MTA 1 Expression in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis. Asian Pac J Cancer Prev. 2017 Nov 26;18(11):2903-2909. doi: 10.22034/APJCP.2017.18.11.2903. PMID: 29172257; PMCID: PMC5773769.